These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31514997)

  • 21. The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.
    Ober BT; Teufel B; Wiesmüller KH; Jung G; Pfaff E; Saalmüller A; Rziha HJ
    J Virol; 2000 Feb; 74(4):1752-60. PubMed ID: 10644346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
    Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
    Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of truncated gE gene of pseudorabies virus (PRV) and primary application in differential diagnosis of PRV vaccination and infection].
    Ni JQ; Zhang CL; Tong GZ; Qiu HJ; Wang YF; Tian ZJ
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):526-31. PubMed ID: 15968982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of changes in the short unique segment of pseudorabies virus BUK-TK900 (Suivac A) vaccine strain.
    Ficińska J; Bieńkowska-Szewczyk K; Jacobs L; Płucienniczak G; Płucienniczak A; Szewczyk B
    Arch Virol; 2003 Aug; 148(8):1593-612. PubMed ID: 12898333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and clinical evaluation of a new gold-immunochromatographic assay for the detection of antibodies against field strains of pseudorabies virus.
    Guo DL; Pan QW; Li KP; Li JQ; Shen HW; Wang XL; Zhang XY; Li XS; Fu F; Feng L; Li X
    J Virol Methods; 2015 Sep; 222():164-9. PubMed ID: 26141732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of pseudorabies virus gE epitopes in Pichia pastoris and its utilization in an indirect PRV gE-ELISA.
    Ao JQ; Wang JW; Chen XH; Wang XZ; Long QX
    J Virol Methods; 2003 Dec; 114(2):145-50. PubMed ID: 14625049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.
    Kit S; Awaya Y; Otsuka H; Kit M
    J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.
    Jacobs L; Rziha HJ; Kimman TG; Gielkens AL; Van Oirschot JT
    Arch Virol; 1993; 131(3-4):251-64. PubMed ID: 8394068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
    Zhou J; Li S; Wang X; Zou M; Gao S
    Vaccine; 2017 Feb; 35(8):1161-1166. PubMed ID: 28131396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
    Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
    BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of a Pseudorabies virus variant with increased virulence to piglets.
    Tong W; Liu F; Zheng H; Liang C; Zhou YJ; Jiang YF; Shan TL; Gao F; Li GX; Tong GZ
    Vet Microbiol; 2015 Dec; 181(3-4):236-40. PubMed ID: 26507829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies.
    Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS
    Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation on pseudorabies prevalence in Chinese swine breeding farms in 2013-2016.
    Liu Y; Zhang S; Xu Q; Wu J; Zhai X; Li S; Wang J; Ni J; Yuan L; Song X; Zhao B; Zhou Z; Wang C; Yang L
    Trop Anim Health Prod; 2018 Aug; 50(6):1279-1285. PubMed ID: 29556961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.
    Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y
    Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in glycoprotein B contribute to immunogenic difference between PRV variant JS-2012 and Bartha-K61.
    Yu ZQ; Tong W; Zheng H; Li LW; Li GX; Gao F; Wang T; Liang C; Ye C; Wu JQ; Huang Q; Tong GZ
    Vet Microbiol; 2017 Sep; 208():97-105. PubMed ID: 28888658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
    Kit M; Kit S
    Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines.
    Weigel RM; Hahn EC; Scherba G
    Vet Microbiol; 2003 Mar; 92(1-2):19-24. PubMed ID: 12488067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response.
    Zaripov MM; Morenkov OS; Siklodi B; Barna-Vetro I; Gyöngyösi-Horvath A; Fodor I
    Res Virol; 1998; 149(1):29-41. PubMed ID: 9561562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.